Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Jürgen Mestan0
Doriano Fabbro0
Paul W. Manley0
Date of Patent
February 23, 2010
0Patent Application Number
119115620
Date Filed
May 2, 2006
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to the use of pyrimidylaminobenzamide derivatives for the preparation of a drug for the treatment of FIP1L1-PDGFRα-induced or TEL-PDGFRβ-induced myeloproliferative diseases, especially for the curative and/or prophylactic treatment of hypereosinophilic syndrome and hypereosinophilic syndrome with resistance to imatinib, and to a method of treating hypereosinophilic syndrome, chronic eosinophilic leukemia and hypereosinophilic syndrome with resistance to imatinib, or other diseases associated with FIP1L1-PDGFRα, TEL-PDGFRβ or similar mutations that activate PDGFR.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
